Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,897.36 +1,473.03 (+2.25%) CMC Crypto 200
1,350.62 -23.22 (-1.67%)
ALXO May 2024 17.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:22AM EDT. Market open.
| Previous close | 1.6000 |
| Open | 1.6000 |
| Bid | 1.1000 |
| Ask | 5.5000 |
| Strike | 17.50 |
| Expiry date | 2024-05-17 |
| Day's range | 1.6000 - 1.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
GuruFocus.comInsider Sale: Chief Medical Officer of ALX Oncology Holdings Inc (ALXO) Sells Shares
Sophia Randolph, Chief Medical Officer of ALX Oncology Holdings Inc (NASDAQ:ALXO), sold 12,000 shares of the company on May 13, 2024.
ZacksWall Street Analysts Think ALX Oncology Holdings (ALXO) Could Surge 36.64%: Read This Before Placing a Bet
The mean of analysts' price targets for ALX Oncology Holdings (ALXO) points to a 36.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- GuruFocus.com
ALX Oncology Holdings Inc (ALXO) Q1 2024 Earnings Analysis: A Detailed Look at Financials and ...
Consistent with Analyst Projections Amidst Clinical Advancements
© 2024 Yahoo. All rights reserved.